Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amos Adler

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Mbio|December 22, 2011
Dissemination of the Klebsiella pneumoniae carbapenemase in the health care settings: tracking the trails of an elusive offenderAmos Adler, Yehuda Carmeli
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 16, 2026
Synergistic and additive in vitro interactions of imipenem, trimethoprim-sulfamethoxazole, amikacin, and clofazimine against clinical isolates of Nocardia wallaceiYizhak Hershko, Amos Adler
American Journal of Infection Control|April 29, 2017
Validation of quality assurance criteria for rectal surveillance culturesMa'ayan Amar, Amos Adler
Diagnostic Microbiology and Infectious Disease|November 28, 2017
Comparative study of 3 carbapenem-hydrolysis methods for the confirmation of carbapenemase production in EnterobacteriaceaeOhad Shalom, Amos Adler
Expert Review of Anti-Infective Therapy|May 19, 2023
Introduction and spread of NDM-producing Enterobacterales and <i>Acinetobacter baumannii</i> into Middle Eastern countries: a molecular-based hypothesisShelley Reich, Amos Adler
Microbial Drug Resistance (Larchmont, N.Y.)|May 23, 2023
Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in IsraelYizhak Hershko, Amos Adler
Journal of Clinical Microbiology|November 20, 2015
Comparative Study of a Novel Biochemical Assay, the Rapidec Carba NP Test, for Detecting Carbapenemase-Producing EnterobacteriaceaeZiv Lifshitz, Amos Adler, Yehuda Carmeli
Journal of Global Antimicrobial Resistance|June 12, 2021
Clinical and epidemiological features of patients colonised by different types of carbapenemase-producing EnterobacteralesRoy Assis, Michal Lasnoy, Amos Adler
Microorganisms|July 29, 2023
The Nocardial <i>aph(2″)</i> Gene Confers Tobramycin and Gentamicin Resistance and Is an Effective Positive Selection Marker in Mycobacteria and NocardiaYizhak Hershko, Amos Adler, Daniel Barkan
Diagnostic Microbiology and Infectious Disease|February 27, 2022
Microbiological and clinical changes following the transition to the 2010 revised CLSI breakpoints for extended-spectrum cephalosporin in EnterobacteralesBen Vaknin, Nancy Bishouty, Amos Adler
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Mbio|December 22, 2011
Dissemination of the Klebsiella pneumoniae carbapenemase in the health care settings: tracking the trails of an elusive offenderAmos Adler, Yehuda Carmeli
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 16, 2026
Synergistic and additive in vitro interactions of imipenem, trimethoprim-sulfamethoxazole, amikacin, and clofazimine against clinical isolates of Nocardia wallaceiYizhak Hershko, Amos Adler
American Journal of Infection Control|April 29, 2017
Validation of quality assurance criteria for rectal surveillance culturesMa'ayan Amar, Amos Adler
Diagnostic Microbiology and Infectious Disease|November 28, 2017
Comparative study of 3 carbapenem-hydrolysis methods for the confirmation of carbapenemase production in EnterobacteriaceaeOhad Shalom, Amos Adler
Expert Review of Anti-Infective Therapy|May 19, 2023
Introduction and spread of NDM-producing Enterobacterales and <i>Acinetobacter baumannii</i> into Middle Eastern countries: a molecular-based hypothesisShelley Reich, Amos Adler
Microbial Drug Resistance (Larchmont, N.Y.)|May 23, 2023
Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in IsraelYizhak Hershko, Amos Adler
Journal of Clinical Microbiology|November 20, 2015
Comparative Study of a Novel Biochemical Assay, the Rapidec Carba NP Test, for Detecting Carbapenemase-Producing EnterobacteriaceaeZiv Lifshitz, Amos Adler, Yehuda Carmeli
Journal of Global Antimicrobial Resistance|June 12, 2021
Clinical and epidemiological features of patients colonised by different types of carbapenemase-producing EnterobacteralesRoy Assis, Michal Lasnoy, Amos Adler
Microorganisms|July 29, 2023
The Nocardial <i>aph(2″)</i> Gene Confers Tobramycin and Gentamicin Resistance and Is an Effective Positive Selection Marker in Mycobacteria and NocardiaYizhak Hershko, Amos Adler, Daniel Barkan
Diagnostic Microbiology and Infectious Disease|February 27, 2022
Microbiological and clinical changes following the transition to the 2010 revised CLSI breakpoints for extended-spectrum cephalosporin in EnterobacteralesBen Vaknin, Nancy Bishouty, Amos Adler
Pageof 15